ID29226A - Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis - Google Patents

Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis

Info

Publication number: ID29226A
Authority: ID; Indonesia
Prior art keywords: cycopeptide; farma; objector; angiogenesis; size
Prior art date: 1998-09-16

Application number

IDW20010746A

Other languages

English (en)

Inventor

Alfred Jonczyk

Astrid Perschl

Simon Goodman

Sigrid Resener

Jutta Haunschild

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-16

Filing date

1999-09-09

Publication date

2001-08-16

1999-09-09 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2001-08-16 Publication of ID29226A publication Critical patent/ID29226A/id

Links

230000033115 angiogenesis Effects 0.000 title 1
239000012829 chemotherapy agent Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Ophthalmology & Optometry (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IDW20010746A 1998-09-16 1999-09-09 Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis ID29226A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19842415A DE19842415A1 (de)	1998-09-16	1998-09-16	Pharmazeutische Zubereitung

Publications (1)

Publication Number	Publication Date
ID29226A true ID29226A (id)	2001-08-16

Family

ID=7881169

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010746A ID29226A (id)	1998-09-16	1999-09-09	Sediaan farma si yang berisi satu siklopeptida dan satu agen kemoterapi atau satu penghambat angiogenesis

Country Status (31)

Country	Link
US (1)	US6683051B1 (id)
EP (2)	EP1466615B1 (id)
JP (2)	JP2002524526A (id)
KR (1)	KR100703253B1 (id)
CN (2)	CN1201812C (id)
AR (2)	AR022382A1 (id)
AT (2)	ATE292470T1 (id)
AU (1)	AU765073B2 (id)
BR (1)	BR9913737A (id)
CA (1)	CA2344151A1 (id)
CO (1)	CO5140070A1 (id)
CZ (1)	CZ302908B6 (id)
DE (3)	DE19842415A1 (id)
DK (2)	DK1466615T3 (id)
ES (2)	ES2327331T3 (id)
HU (1)	HUP0103521A3 (id)
ID (1)	ID29226A (id)
IL (2)	IL141516A0 (id)
MY (1)	MY129572A (id)
NO (1)	NO331734B1 (id)
NZ (1)	NZ510040A (id)
PE (1)	PE20001046A1 (id)
PL (1)	PL201902B1 (id)
PT (2)	PT1113809E (id)
RU (1)	RU2227041C2 (id)
SI (1)	SI1113809T1 (id)
SK (1)	SK287012B6 (id)
TR (1)	TR200100765T2 (id)
TW (1)	TW576744B (id)
WO (1)	WO2000015244A2 (id)
ZA (1)	ZA200103073B (id)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7740841B1 (en) *	2000-01-28	2010-06-22	Sunnybrook Health Science Center	Therapeutic method for reducing angiogenesis
KR20030068205A (ko) *	2001-01-09	2003-08-19	메르크 파텐트 게엠베하	수용체 타이로신 키나아제 저해제 및 혈관형성 저해제를사용하는 병용 요법
JP4542783B2 (ja) *	2002-03-05	2010-09-15	エーザイ・アール・アンド・ディー・マネジメント株式会社	スルホンアミド含有複素環化合物及び血管新生抑制剤とを組み合わせてなる抗腫瘍剤
PL1734996T3 (pl) *	2004-04-02	2013-09-30	Univ California	Sposoby i kompozycje do leczenia i profilaktyki choroby związanej z integryną alfa v beta 5
CN104857500A (zh) *	2005-11-02	2015-08-26	杜克大学	同时的化学疗法和免疫疗法
US20110165150A1 (en) *	2006-01-18	2011-07-07	Merck Patent Gmbh	Isolated organ perfusion combination therapy of cancer
AU2007207465B2 (en) *	2006-01-18	2012-12-06	Merck Patent Gmbh	Specific therapy using integrin ligands for treating cancer
BRPI0806596A2 (pt)	2007-01-18	2013-07-23	Merck Patent Ges Mit Berchraenkter Haftung	medicamento e terapia especÍfica usando-se ligantes de integrina para o tratamento de cÂncer
EP2526967A1 (en)	2007-07-17	2012-11-28	Merck Patent GmbH	Engineered anti-alpha v-integrin hybrid antibodies
WO2010051667A1 (zh) *	2008-11-10	2010-05-14	复旦大学	一种环肽纳米管药物组合物及其应用
CA2744134A1 (en) *	2008-11-20	2010-05-27	Merck Patent Gmbh	New therapy and medicament using integrin ligands for treating cancer
EP2445534A2 (en)	2009-05-25	2012-05-02	Merck Patent GmbH	Continuous administration of cilengitide in cancer treatments
CA2767409C (en)	2009-07-24	2018-10-30	The Regents Of The University Of California	Methods and compositions for treating and preventing disease associated with .alpha.v.beta.5 integrin
MX2012006450A (es)	2009-12-10	2012-06-28	Merck Patent Gmbh	Composicion farmaceutica que comprende oligopeptidos.
AU2011278700A1 (en)	2010-07-16	2013-02-28	Merck Patent Gmbh	Peptide for use in the treatment of breast cancer and/or bone metastases
WO2012069149A1 (en)	2010-11-23	2012-05-31	Merck Patent Gmbh	Solution comprising cyclic oligopeptides
WO2012107211A1 (en)	2011-02-11	2012-08-16	Merck Patent Gmbh	Anti-alpha-v integrin antibody for the treatment of prostate cancer
WO2012110200A1 (en)	2011-02-18	2012-08-23	Merck Patent Gmbh	Cyclic peptide cyclo (l -arginyl - glycyl - l -aspartyl - d - phenylalanyl - n-methyl - l -valyl), compositions thereof, and use thereof in methods for treating graft -versus - host disease
AU2012266803B2 (en) *	2011-06-09	2017-02-02	Merck Patent Gmbh	Treatment of cancers and metastases with suspensions of cilengitide in carrier
WO2013130775A1 (en) *	2012-03-01	2013-09-06	Dizerega, Gere, S.	Methods for treating patients undergoing multi-cycle chemotherapy
CN103333227B (zh) *	2013-06-07	2015-10-07	东南大学	转移肿瘤缺失蛋白小分子环肽抑制剂及其制备方法与应用
US20190242908A1 (en)	2016-09-08	2019-08-08	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods for diagnosing and treating nephrotic syndrome
JP2019208422A (ja) *	2018-06-04	2019-12-12	コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー	ヒアルロニダーゼを含む新規な組換えエキソソーム及びその用途
GB201911816D0 (en) *	2019-08-16	2019-10-02	Univ London Queen Mary	Treatment
GB202103122D0 (en) *	2021-03-05	2021-04-21	Univ London Queen Mary	Treatment

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04367367A (ja)	1991-06-11	1992-12-18	Nkk Corp	ロータリノズル
RU2116081C1 (ru) *	1992-07-06	1998-07-27	Мерк Патент Гмбх	Циклические ингибиторы адгезии
JP3322878B2 (ja)	1992-10-14	2002-09-09	メルクエンドカンパニーインコーポレーテッド	フィブリノーゲンレセプターアンタゴニスト
WO1994012181A1 (en)	1992-12-01	1994-06-09	Merck & Co., Inc.	Fibrinogen receptor antagonists
DE4310643A1 (de) *	1993-04-01	1994-10-06	Merck Patent Gmbh	Cyclische Adhäsionsinhibitoren
CA2190870A1 (en)	1994-05-27	1995-12-07	George D. Hartman	Compounds for inhibiting osteoclast-mediated bone resorption
ZA955391B (en)	1994-06-29	1996-02-09	Smithkline Beecham Corp	Vitronectin receptor antagonists
AU702661B2 (en)	1994-06-29	1999-02-25	Smithkline Beecham Corporation	Vitronectin receptor antagonists
ATE170179T1 (de)	1994-11-02	1998-09-15	Merck Patent Gmbh	Adhäsionsrezeptor-antagonisten
DE19534177A1 (de) *	1995-09-15	1997-03-20	Merck Patent Gmbh	Cyclische Adhäsionsinhibitoren
DE19548709A1 (de) *	1995-12-23	1997-07-03	Merck Patent Gmbh	Tyrosinderivate
JPH09208571A (ja) *	1996-02-02	1997-08-12	Takeda Chem Ind Ltd	アルキリデンシクロヘキサン誘導体
WO1997041844A1 (en) *	1996-05-09	1997-11-13	Alcon Laboratories, Inc.	Combinations of angiostatic compounds
US5919815A (en) *	1996-05-22	1999-07-06	Neuromedica, Inc.	Taxane compounds and compositions
KR20000016301A (ko) *	1996-05-31	2000-03-25	빙검 더글라스 에이.	혈관 형성 억제에 유용한 방법 및 조성물
JPH1081631A (ja) *	1996-07-17	1998-03-31	Takeda Chem Ind Ltd	癌転移または再発抑制剤
DE19629817A1 (de)	1996-07-24	1998-01-29	Hoechst Ag	Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19629816A1 (de)	1996-07-24	1998-01-29	Hoechst Ag	Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
UA60311C2 (uk)	1996-10-02	2003-10-15	Смітклайн Бічам Корпорейшн	Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
AU729869B2 (en) *	1997-01-17	2001-02-15	Merck & Co., Inc.	Integrin antagonists
WO1998041844A1 (de) *	1997-03-19	1998-09-24	Heribert Broicher	Verfahren und vorrichtung zur ermittlung eines kennwertes eines stoffes mittels fotolumineszenz
DE19850131A1 (de)	1998-10-30	2000-05-04	Merck Patent Gmbh	Chromenon- und Chromanonderivate

1998
- 1998-09-16 DE DE19842415A patent/DE19842415A1/de not_active Withdrawn
1999
- 1999-09-09 PL PL348026A patent/PL201902B1/pl not_active IP Right Cessation
- 1999-09-09 ES ES04006076T patent/ES2327331T3/es not_active Expired - Lifetime
- 1999-09-09 ID IDW20010746A patent/ID29226A/id unknown
- 1999-09-09 CN CNB998133876A patent/CN1201812C/zh not_active Expired - Fee Related
- 1999-09-09 EP EP04006076A patent/EP1466615B1/de not_active Expired - Lifetime
- 1999-09-09 IL IL14151699A patent/IL141516A0/xx unknown
- 1999-09-09 US US09/787,374 patent/US6683051B1/en not_active Expired - Lifetime
- 1999-09-09 AT AT99969031T patent/ATE292470T1/de active
- 1999-09-09 BR BR9913737-2A patent/BR9913737A/pt not_active Application Discontinuation
- 1999-09-09 DE DE59911881T patent/DE59911881D1/de not_active Expired - Lifetime
- 1999-09-09 AT AT04006076T patent/ATE432707T1/de active
- 1999-09-09 PT PT99969031T patent/PT1113809E/pt unknown
- 1999-09-09 WO PCT/EP1999/006654 patent/WO2000015244A2/de not_active Ceased
- 1999-09-09 RU RU2001110104/15A patent/RU2227041C2/ru not_active IP Right Cessation
- 1999-09-09 SI SI9930792T patent/SI1113809T1/xx unknown
- 1999-09-09 CA CA002344151A patent/CA2344151A1/en not_active Abandoned
- 1999-09-09 EP EP99969031A patent/EP1113809B1/de not_active Expired - Lifetime
- 1999-09-09 CN CNB2004100834955A patent/CN100352494C/zh not_active Expired - Fee Related
- 1999-09-09 KR KR1020017003238A patent/KR100703253B1/ko not_active Expired - Fee Related
- 1999-09-09 JP JP2000569828A patent/JP2002524526A/ja active Pending
- 1999-09-09 HU HU0103521A patent/HUP0103521A3/hu unknown
- 1999-09-09 CZ CZ20010932A patent/CZ302908B6/cs not_active IP Right Cessation
- 1999-09-09 DK DK04006076T patent/DK1466615T3/da active
- 1999-09-09 PT PT04006076T patent/PT1466615E/pt unknown
- 1999-09-09 ES ES99969031T patent/ES2241363T3/es not_active Expired - Lifetime
- 1999-09-09 TR TR2001/00765T patent/TR200100765T2/xx unknown
- 1999-09-09 AU AU59758/99A patent/AU765073B2/en not_active Ceased
- 1999-09-09 DE DE59915033T patent/DE59915033D1/de not_active Expired - Lifetime
- 1999-09-09 SK SK337-2001A patent/SK287012B6/sk not_active IP Right Cessation
- 1999-09-09 DK DK99969031T patent/DK1113809T3/da active
- 1999-09-09 NZ NZ510040A patent/NZ510040A/en not_active IP Right Cessation
- 1999-09-13 PE PE1999000926A patent/PE20001046A1/es not_active Application Discontinuation
- 1999-09-13 MY MYPI99003955A patent/MY129572A/en unknown
- 1999-09-15 AR ARP990104617A patent/AR022382A1/es not_active Application Discontinuation
- 1999-09-16 CO CO99058733A patent/CO5140070A1/es unknown
- 1999-09-16 TW TW088116003A patent/TW576744B/zh not_active IP Right Cessation
2001
- 2001-02-19 IL IL141516A patent/IL141516A/en not_active IP Right Cessation
- 2001-03-15 NO NO20011308A patent/NO331734B1/no not_active IP Right Cessation
- 2001-04-12 ZA ZA200103073A patent/ZA200103073B/en unknown
2010
- 2010-09-15 AR ARP100103356A patent/AR078175A2/es not_active Application Discontinuation
2011
- 2011-08-12 JP JP2011176480A patent/JP2011252012A/ja active Pending

Also Published As

Publication number	Publication date
EP1113809A2 (de)	2001-07-11
WO2000015244A2 (de)	2000-03-23
CN100352494C (zh)	2007-12-05
PE20001046A1 (es)	2000-10-14
IL141516A0 (en)	2002-03-10
CN1329499A (zh)	2002-01-02
CA2344151A1 (en)	2000-03-23
DK1113809T3 (da)	2005-08-08
DE19842415A1 (de)	2000-03-23
NO331734B1 (no)	2012-03-12
KR20010073155A (ko)	2001-07-31
DK1466615T3 (da)	2009-08-31
MY129572A (en)	2007-04-30
ES2241363T3 (es)	2005-10-16
NO20011308L (no)	2001-03-15
PL348026A1 (en)	2002-05-06
WO2000015244A3 (de)	2000-06-22
ATE292470T1 (de)	2005-04-15
NZ510040A (en)	2003-12-19
ZA200103073B (en)	2002-08-21
ATE432707T1 (de)	2009-06-15
CN1636590A (zh)	2005-07-13
EP1466615A1 (de)	2004-10-13
HUP0103521A3 (en)	2002-05-28
CN1201812C (zh)	2005-05-18
US6683051B1 (en)	2004-01-27
NO20011308D0 (no)	2001-03-15
SK3372001A3 (en)	2001-11-06
DE59915033D1 (de)	2009-07-16
AR078175A2 (es)	2011-10-19
CZ302908B6 (cs)	2012-01-18
AU765073B2 (en)	2003-09-11
EP1113809B1 (de)	2005-04-06
SI1113809T1 (en)	2005-10-31
DE59911881D1 (de)	2005-05-12
KR100703253B1 (ko)	2007-04-03
AR022382A1 (es)	2002-09-04
JP2002524526A (ja)	2002-08-06
CO5140070A1 (es)	2002-03-22
SK287012B6 (sk)	2009-09-07
CZ2001932A3 (cs)	2001-09-12
ES2327331T3 (es)	2009-10-28
AU5975899A (en)	2000-04-03
EP1466615B1 (de)	2009-06-03
PT1113809E (pt)	2005-08-31
JP2011252012A (ja)	2011-12-15
IL141516A (en)	2009-09-22
PL201902B1 (pl)	2009-05-29
RU2227041C2 (ru)	2004-04-20
BR9913737A (pt)	2001-06-05
TR200100765T2 (tr)	2001-08-21
PT1466615E (pt)	2009-09-07
TW576744B (en)	2004-02-21
HUP0103521A2 (hu)	2002-02-28

Publication	Publication Date	Title
GB2326893B (en)	2001-12-19	Thru-tubing anchor seal assembly and/or packer release devices
DE69811357D1 (de)	2003-03-20	Brausezusammensetzungen sowie trockene brausegranulate
NO954276D0 (no)	1995-10-26	Surgjöring av underjordiske reservoarer
ID17225A (id)	1997-12-11	Komposisi-komposisi semen dan pemakaiannya untuk penyemenan sumur-sumur minyak atau yang sejenisnya
NO981099L (no)	1998-09-15	Vannbaserte sammensetninger for tetning av underjordiske soner samt fremgangsmÕter
ID20586A (id)	1999-01-21	Skeloroglukan baru dan komposisi kosmetik yang mengandung senyawa baru
ID19089A (id)	1998-06-11	Kain bukan tenunan yang memiliki kemiringan ukuran pori dan metode serta aparat pembuatannya
GB9800795D0 (en)	1998-03-11	Prevention of multiple use of limited use devices
GB2368841B (en)	2004-03-31	Cementing compositions and application of such compositions for cementing oil wells or the like
ID22957A (id)	1999-12-23	Senyawa dan penggunaannya
DE69806914D1 (de)	2002-09-05	Agentimplementierte verriegelungsvorrichtung
ID24839A (id)	2000-08-24	Senyawa-senyawa triazol dan penggunaannya
FI974646A0 (fi)	1997-12-30	Utjaemning av stoerningar i mobilkommunicationssystem
AU1617997A (en)	1997-08-28	Combination of materials for the low temperature triggering of the activation of getter materials and getter devices containing the same
ID26945A (id)	2001-02-22	Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan
ID16856A (id)	1997-11-13	Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan
ID21783A (id)	1999-07-22	Komposisi-komposisi serbuk yang berdasarkan pada poliester semi-kristal dan berdasarkan pada poliester amorf yang mengandung gugus akhir metakriloil
ID16517A (id)	1997-10-09	Metode dan peralatan sumur untuk kerikil yang membungkus sumur yang menggunakan cairan kepekatan rendah
ID26402A (id)	2000-12-21	Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya
GB2326895B (en)	1999-08-18	Seperation of oil-well fluid mixtures
PL340838A1 (en)	2001-02-26	Application of the renin-angiotensin system inhibitors
PL334517A1 (en)	2000-02-28	Clavulate and one or more of exicipients containing granules
GT200000143A (es)	2002-02-20	Empleo de formulaciones que contienen polisiloxano y agente deslizante de cadenas.
ID18682A (id)	1998-04-30	Asiltransferase dan plasma yang mengkodekan asiltransferase
ID28382A (id)	2001-05-17	Bahan anti keringat dan komposisi-komposisi yang mengandung bahan anti keringat